Basit öğe kaydını göster

dc.contributor.authorKarakas, Zeynep
dc.contributor.authorKaraman, Serap
dc.contributor.authorSalman, Nuran
dc.contributor.authorSomer, Ayper
dc.contributor.authorSutcu, Murat
dc.contributor.authorKara, Manolya
dc.contributor.authorAnak, Sema
dc.contributor.authorAkturk, Hacer
dc.date.accessioned2021-03-05T12:46:10Z
dc.date.available2021-03-05T12:46:10Z
dc.date.issued2018
dc.identifier.citationSutcu M., Akturk H., Karaman S., Kara M., Karakas Z., Salman N., Anak S., Somer A., "Posaconazole with Combination Salvage Treatment in Pediatric Immunocompromised Patients", JOURNAL OF PEDIATRIC INFECTION, cilt.12, ss.8-14, 2018
dc.identifier.othervv_1032021
dc.identifier.otherav_aec97595-254e-4fa2-82ab-ff7e6d4fc7b5
dc.identifier.urihttp://hdl.handle.net/20.500.12627/116602
dc.identifier.urihttps://doi.org/10.5578/ced.201802
dc.description.abstractObjective: Posaconazole is a recently developed wide-spectrum antifungal medication for which insufficient data is available regarding its potential pediatric use as a salvage therapy for systemic fungal infections in Turkey. The present study makes a retrospective review of the use of posaconazole as a salvage therapy.
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectÇocuk Sağlığı ve Hastalıkları
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectPEDİATRİ
dc.titlePosaconazole with Combination Salvage Treatment in Pediatric Immunocompromised Patients
dc.typeMakale
dc.relation.journalJOURNAL OF PEDIATRIC INFECTION
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume12
dc.identifier.issue1
dc.identifier.startpage8
dc.identifier.endpage14
dc.contributor.firstauthorID251774


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster